MMRF's CoMMpass Study Highlights and Moves Research of Myeloma Forward
December 10, 2014
Anne Young Quinn, of the MMRF, explains the catalyst behind the CoMMpass study and how it may be changing the future of myeloma treatment.
The Multiple Myeloma Research Foundation initiated the CoMMpass study in 2011. The study, which is nearing enrollment completion, uses clinical samples from participants enrolled in the study to help unravel genetic secrets that could lead to new and better treatments for myeloma.
Anne Young Quinn, of the MMRF, explains the catalyst behind the CoMMpass study and how it may be changing the future of myeloma treatment.
